MediciNova closes $7.5M private stock sale to Kissei
This article was originally published in Scrip
Executive Summary
MediciNova, which is traded on both the NASDAQ market and the Jasdaq market of the Osaka Securities Exchange, has closed on its $7.5 million private stock sale to Kissei Pharmaceutical, a company traded on the Tokyo Stock Exchange.